Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.
A wealth of research over the last 30 years has strongly indicated that stroke recovery can be significantly improved through immersive stimulation and robotic assistance.
The Torque3 system leverages this research with an approach of uncompromising design and implementation combining a robotic chair and virtual reality.
In this episode, Founder/CEO David Ellzey shares some of the science behind Torque3 and insights into where they are headed.
Neobe Therapeutics is an early-stage startup engineering safe recombinant bacterial products to enable immune infiltration in solid tumors. Their bacterial products combine innate tumor...
Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role...
iVizz, is a Bay Area technology company which enables hospitals to prevent in-patient infections outbreaks.https://www.angelmd.co/en/startups/ivizz
